High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.
Publication Type:
Journal ArticleSource:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Volume 28, Issue 17, p.2831-8 (2010)Keywords:
2010, Adolescent, Adult, Age Factors, Center-Authored Paper, Child, Child, Preschool, Clinical Research Division, Clinical Trials, Phase III as Topic, Cohort Studies, Flow Cytometry Core Facility, Humans, Infant, Integrin alpha4beta1, Leukemia, Myeloid, Acute, Male, Prognosis, Prospective Studies, Treatment Outcome, Young AdultAbstract:
To evaluate the prognostic significance of the integrin cell adhesion molecule very late antigen-4 (VLA-4) in acute myeloid leukemia (AML).
Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)